Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
Mary Eapen(Medical College of Wisconsin), Mary M. Horowitz(Medical College of Wisconsin), Wendy B. London(Dana-Farber Cancer Institute), Victoria H. Coleman‐Cowger(University of Maryland, Baltimore), Michael A. Pulsipher(Primary Children's Hospital), Erica B. Esrick(Broad Institute), Edmund K. Waller(Emory University), Benjamin L. Jacobs(Medical College of Wisconsin), Joshua J. Field(Versiti Blood Center of Wisconsin), Alexis A. Thompson(Children's Hospital of Philadelphia), Mark C. Walters(UCSF Benioff Children's Hospital), Donald B. Kohn(University of California, Los Angeles), Joseph H. Antin(Dana-Farber Cancer Institute), Ruta Brazauskas(Medical College of Wisconsin), David A. Williams(Boston Children's Hospital), Lakshmanan Krishnamurti(Emory University), Julie Kanter(University of Alabama at Birmingham), Sonali Chaudhury(Northwestern University), Sohel Talib(California Institute for Regenerative Medicine), Andrew St. Martin(Johns Hopkins Hospital), Kira Bona(Dana-Farber Cancer Institute), Courtney D. Fitzhugh(National Institutes of Health), Ted Wun(UC Davis Comprehensive Cancer Center), Neena Kapoor(University of Southern California), Nancy DiFronzo(National Heart Lung and Blood Institute)
Cited by 56
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Gene therapy comes of age
|Science|2018|1.4k
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k